GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
OSL:GENT - NO0010748866 - Common Stock
55.8 NOK
-0.2 (-0.36%)
Taking everything into account, GENT scores 6 out of 10 in our fundamental rating. GENT was compared to 58 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year GENT was profitable.
GENT had a positive operating cash flow in the past year.
GENT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of GENT (18.25%) is better than 94.83% of its industry peers.
GENT has a better Return On Equity (21.37%) than 87.93% of its industry peers.
GENT has a Return On Invested Capital of 7.59%. This is in the better half of the industry: GENT outperforms 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 25.83%, GENT belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
Looking at the Operating Margin, with a value of 12.10%, GENT is in line with its industry, outperforming 56.90% of the companies in the same industry.
With a Gross Margin value of 54.19%, GENT perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GENT is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GENT has about the same amount of shares outstanding.
Compared to 1 year ago, GENT has an improved debt to assets ratio.
2.2 Solvency
GENT has an Altman-Z score of 16.32. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
GENT has a Altman-Z score of 16.32. This is amongst the best in the industry. GENT outperforms 100.00% of its industry peers.
GENT has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
The Debt to FCF ratio of GENT (0.33) is better than 93.10% of its industry peers.
GENT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GENT (0.02) is better than 91.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 16.32 |
ROIC/WACC0.9
WACC8.46%
2.3 Liquidity
A Current Ratio of 5.47 indicates that GENT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.47, GENT belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
GENT has a Quick Ratio of 3.78. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.78, GENT belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 2103.43% over the past year.
GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.68%.
The Revenue has been growing by 25.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 62.29% on average per year.
The Revenue is expected to grow by 31.72% on average over the next years. This is a very strong growth
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.74, which indicates a rather expensive current valuation of GENT.
Based on the Price/Earnings ratio, GENT is valued a bit cheaper than 79.31% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, GENT is valued a bit cheaper.
The Price/Forward Earnings ratio is 20.57, which indicates a rather expensive current valuation of GENT.
Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
GENT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.74 | ||
| Fwd PE | 20.57 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as GENT.
The rest of the industry has a similar Price/Free Cash Flow ratio as GENT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 90.91 | ||
| EV/EBITDA | 27.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GENT's earnings are expected to grow with 62.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.73%, GENT is not a good candidate for dividend investing.
GENT's Dividend Yield is a higher than the industry average which is at 2.16.
Compared to an average S&P500 Dividend Yield of 2.45, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.73% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (9/8/2025, 4:00:57 PM)
55.8
-0.2 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap860.44M
Analysts85.71
Price Target68.34 (22.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.73% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.55%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.74 | ||
| Fwd PE | 20.57 | ||
| P/S | 5.27 | ||
| P/FCF | 90.91 | ||
| P/OCF | 43.25 | ||
| P/B | 4.36 | ||
| P/tB | 5.19 | ||
| EV/EBITDA | 27.31 |
EPS(TTM)2.69
EY4.82%
EPS(NY)2.71
Fwd EY4.86%
FCF(TTM)0.61
FCFY1.1%
OCF(TTM)1.29
OCFY2.31%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.35
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 16.32 |
F-Score5
WACC8.46%
ROIC/WACC0.9
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A